Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Developing a membrane-proximal CD33-targeting CAR T cell.
Freeman R, Shahid S, Khan AG, Mathew SC, Souness S, Burns ER, Um JS, Tanaka K, Cai W, Yoo S, Dunbar A, Park Y, McAvoy D, Hosszu KK, Levine RL, Boelens JJ, Lorenz IC, Brentjens RJ, Daniyan AF. Freeman R, et al. Among authors: brentjens rj. J Immunother Cancer. 2024 May 20;12(5):e009013. doi: 10.1136/jitc-2024-009013. J Immunother Cancer. 2024. PMID: 38772686 Free PMC article.
Endogenous CD28 drives CAR T cell responses in multiple myeloma.
Lieberman MM, Tong JH, Odukwe NU, Chavel CA, Purdon TJ, Burchett R, Gillard BM, Brackett CM, McGray AJR, Bramson JL, Brentjens RJ, Lee KP, Olejniczak SH. Lieberman MM, et al. Among authors: brentjens rj. bioRxiv [Preprint]. 2024 Apr 9:2024.03.21.586084. doi: 10.1101/2024.03.21.586084. bioRxiv. 2024. PMID: 38562904 Free PMC article. Preprint.
Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
Zakrzewski JL, Suh D, Markley JC, Smith OM, King C, Goldberg GL, Jenq R, Holland AM, Grubin J, Cabrera-Perez J, Brentjens RJ, Lu SX, Rizzuto G, Sant'Angelo DB, Riviere I, Sadelain M, Heller G, Zúñiga-Pflücker JC, Lu C, van den Brink MRM. Zakrzewski JL, et al. Among authors: brentjens rj. Nat Biotechnol. 2024 Apr;42(4):674. doi: 10.1038/s41587-024-02205-3. Nat Biotechnol. 2024. PMID: 38531977 No abstract available.
MEETING HIGHLIGHTS: THE THIRD MARIE SKŁODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023.
Kalinski P, Kokolus KM, Azrak R, Berezin MY, Brentjens R, Czerniecki B, Dubrov S, Eaton K, Hyland A, Kisailus A, Kortylewski M, Koski GK, Kotula L, Gandhi S, Griffiths EA, Ługowska I, Matosevic S, McAleer C, Mikuła M, Nishimura MI, Noyes K, Orabina T, Ozretić P, Paragh G, Parascandola M, Pašukonienė V, Perl A, Powell DJ Jr, Priebe W, Repasky EA, Rudnicki M, Singh AK, Sarnowska E, Sužiedėlis K, Titkova A, Utz K, Wei WZ, Rutkowski P. Kalinski P, et al. Among authors: brentjens r. Wiad Lek. 2023;76(12):2543-2555. doi: 10.36740/WLek202312101. Wiad Lek. 2023. PMID: 38290016
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
Park JH, Nath K, Devlin SM, Sauter CS, Palomba ML, Shah G, Dahi P, Lin RJ, Scordo M, Perales MA, Shouval R, Tomas AA, Cathcart E, Mead E, Santomasso B, Holodny A, Brentjens RJ, Riviere I, Sadelain M. Park JH, et al. Among authors: brentjens rj. Nat Med. 2023 Jul;29(7):1710-1717. doi: 10.1038/s41591-023-02404-6. Epub 2023 Jul 3. Nat Med. 2023. PMID: 37400640 Clinical Trial.
CAR T cell therapy: looking back and looking forward.
Davila ML, Brentjens RJ. Davila ML, et al. Among authors: brentjens rj. Nat Cancer. 2022 Dec;3(12):1418-1419. doi: 10.1038/s43018-022-00484-w. Nat Cancer. 2022. PMID: 36539498 No abstract available.
GPRC5D-Targeted CAR T Cells for Myeloma. Reply.
Mailankody S, Brentjens RJ, Smith EL. Mailankody S, et al. Among authors: brentjens rj. N Engl J Med. 2022 Dec 15;387(24):2296. doi: 10.1056/NEJMc2213985. N Engl J Med. 2022. PMID: 36516098 No abstract available.
152 results